BioSpace News Archive

Business

Evoke Pharma Signs Commercial Agreement with Thermo Fisher Scientific

Under the five-year agreement, Thermo Fisher will manufacture Gimoti for Evoke’s potential commercial efforts.

November 9, 2017
·
4 min read
Business

Novelion Therapeutics Reports Third Quarter 2017 Financial Results and Announces Leadership Change

The company has commenced a search for a new CEO to lead the Company in the next stage of growth.

November 9, 2017
·
23 min read
Pharm Country

Tobii Pro Launches New Advancement in Eye Trackers for Behavioral Research

In conjunction with the initiation of the Spain clinical site, Abeona has established a local subsidiary to manage clinical trial and regulatory development efforts in Europe.

November 9, 2017
·
2 min read
Business

Sienna Biopharmaceuticals Reports Third Quarter 2017 Financial Results

Total operating expenses for the three months ended Sept. 30, 2017, were approximately $14.3 million.

November 9, 2017
·
1 min read
Decisions of Herantis Pharma Plc’s Extraordinary General Meeting of Shareholders

The Extraordinary General Meeting of Shareholders resolved to authorise the Board of Directors, as proposed by the Board of Directors, to decide on the issuance of shares.

November 9, 2017
·
2 min read
Business

SQI Diagnostics to Announce Fourth Quarter and Fiscal 2017 Results

President and CEO, Andrew Morris, along with Company management, will host a conference call on Friday, November 17, 2017 at 10:00 a.m. ET to review financial results and discuss business developments for the period.

November 9, 2017
·
2 min read
Business

PharMerica Reports Third Quarter 2017 Results

Revenues for the third quarter of 2017 were $595.1 million compared with $512.6 million for the third quarter of 2016.

November 9, 2017
·
17 min read
Bio-Tissue Announces First Study to Demonstrate Corneal Nerve Regeneration in Patients With Dry Eye Disease With the Use of PROKERA

The study results will be presented at the upcoming American Academy of Ophthalmology (AAO) meeting taking place November 11 – 14, 2017 in New Orleans.

November 9, 2017
·
3 min read
Business

Repligen Reports Third Quarter 2017 Financial Results

Revenue for the third quarter of 2017 increased to $36.6 million compared to $24.7 million for the third quarter of 2016, a year-over-year gain of 48% as recorded, or 47% at constant currency.

November 9, 2017
·
20 min read
Business

Interpace Diagnostics to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results and Business Progress on Monday November 13, 2017

The live webcast and subsequent replay may be accessed by visiting Interpace’s website www.interpacediagnostics.com.

November 9, 2017
·
3 min read